postMONARCH
postMONARCH: Abemaciclib + Fulvestrant vs Fulvestrant Monotherapy for HR+/HER2- Advanced BC After Progression on CDK4/6 Inhibitor + ET

Released: June 03, 2024

Expiration: June 02, 2025

Activity

Progress
1
Course Completed